Results 221 to 230 of about 61,679 (338)

The changing scenario of retinopathy of prematurity in middle and low income countries: Unique solutions for unique problems

, 2019
Anand Vinekar, Mangat Dogra, RajVardhan Azad, Clare Gilbert, Lingam Gopal, Michael T. Trese   +5 more
openalex   +1 more source

Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatment. [PDF]

, 2015
Darlow, Brian, Deorari, Ashok, Fielder, Alistair, Gilbert, Clare, Quinn, Graham, Vinekar, Anand, Wormald, Richard, Zepeda-Romero, Luz Consuelo, Zin, Andrea   +8 more
core   +1 more source

PDZK1 Protects Against RPE Senescence by Targeting the 14‐3‐3ε‐mTOR Axis to Attenuate Early Diabetic Retinopathy

Advanced Science, Volume 12, Issue 43, November 20, 2025.
PDZK1 down‐regulation couples high‐glucose stress to RPE senescence via a PDZK1–14‐3‐3ε–mTOR axis. Restoring PDZK1 or clearing senescent cells rescues retinal homeostasis and mitigates early diabetic retinopathy (DR). This study provides direct evidence linking RPE cell senescence to DR pathogenesis and reveals a promising therapeutic strategy for DR ...
Jian Zhao, Junbiao Zhang, Yanli Liu, Lili Wang, Chunxi Huang, Wei Chi, Meixia An   +6 more
wiley   +1 more source

Analysis of risk factors for retinopathy of prematurity: a single-center retrospective cohort study. [PDF]

Transl Pediatr
Wu Y.
europepmc   +1 more source

Biomimetic Thalidomide Nanoparticles: Targeted and Sustained Therapeutic Strategy for Oxygen‐Induced Retinopathy

Aggregate, Volume 6, Issue 11, November 2025.
Magnesium acetyl taurate and thalidomide co‐assembled nanoparticles (MT NPs) are prepared via Super‐stable Pure Nanomedicine Formulation Technology (SPFT), and the NPs are further coated with transferrin‐modified cell membrane vesicles to construct Tfm@MT nanomedicine for oxygen‐induced retinopathy treatment.
Mengdie Li, Shundong Cai, Jinfa Ye, Lang Ke, Guanxiong Yang, Shaopan Wang, Cuiting Chen, Peixin Cai, Hui Liu, Xingyuan Wei, Songyi Wang, Yun Han, Shilong Shao, Min Su, Gang Liu, Chengchao Chu   +15 more
wiley   +1 more source

OCT-Derived Quantitative Measurement of Extent of Vascularization ("Zone") in Retinopathy of Prematurity. [PDF]

Ophthalmol Sci
Sutter DA, Woodward MK, Jackson J, Bayhaqi Y, Coyner AS, Ni S, Ostmo S, Lima TT, Nagiel A, Chiang MF, Young BK, Jian Y, Campbell JP.   +12 more
europepmc   +1 more source

Retinopathy of prematurity – developing too soon in babies born too early : A report of three cases

, 2023
Tokunbo Obajolowo, L.B. Olokoba, Victoria A. Olatunji, Dupe Ademola-Popoola, Omotayo Adesiyun, O S Mokuolu   +5 more
openalex   +1 more source

Cardiovascular Safety of VIAN‐c4551, an Antiangiogenic Peptide Derived From Vasoinhibin

Drug Development Research, Volume 86, Issue 7, November 2025.
ABSTRACT Vasoinhibin is a potent antiangiogenic protein that blocks the activation of endothelial nitric oxide synthase (eNOS) in response to vascular endothelial growth factor, bradykinin, and acetylcholine (ACh). In this regard, VIAN‐c4551, a new synthetic vasoinhibin analog, has therapeutic potential for targeting angiogenesis in oncology and ...
Miguel A. García‐González, Alejandro D. Miguel‐Martínez, Abimael González‐Hernández, Magdalena Zamora, Elva Adán‐Castro, Xarubet Ruíz‐Herrera, María A. Carbajo‐Mata, Jakob Triebel, Thomas Bertsch, José G. Lopez‐Lopez, Gonzalo Martínez de la Escalera, Juan Pablo Robles, Carmen Clapp, Carlos M. Villalón   +13 more
wiley   +1 more source

Epidemiological Profile of Retinopathy of Prematurity in Central India. [PDF]

Cureus
Joshi RS, Singh H, Joshi R, Tekade P, Patil AS.   +4 more
europepmc   +1 more source

Retinopathy of Prematurity: 9 years of Epidemiological Analysis in a Mexican Institution of Ophthalmology.

, 2017
Veronica Adriana Romero Morales, Renata García Franco, Miguel Vazquez, Ximena Mira, Doris Ponce de Leon   +4 more
openalex   +1 more source